期刊
MOLECULES
卷 26, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/molecules26040976
关键词
NLRP3; inflammasome; caspase-1; ASC; IL-1; IL-18; cardiovascular disease; ischemia; heart failure; inhibitor
资金
- NIH [R01HL150115]
- Kiniksa
- Olatec
- Serpin Pharma
NLRP3 inflammasome is a crucial player in cardiovascular diseases, regulating cell survival through the production of inflammatory mediators and being a target for inhibitors to block its harmful effects.
Virtually all types of cardiovascular diseases are associated with pathological activation of the innate immune system. The NACHT, leucine-rich repeat (LRR), and pyrin domain (PYD)-containing protein 3 (NLRP3) inflammasome is a protein complex that functions as a platform for rapid induction of the inflammatory response to infection or sterile injury. NLRP3 is an intracellular sensor that is sensitive to danger signals, such as ischemia and extracellular or intracellular alarmins during tissue injury. The NLRP3 inflammasome is regulated by the presence of damage-associated molecular patterns and initiates or amplifies inflammatory response through the production of interleukin-1 beta (IL-1 beta) and/or IL-18. NLRP3 activation regulates cell survival through the activity of caspase-1 and gasdermin-D. The development of NLRP3 inflammasome inhibitors has opened the possibility to targeting the deleterious effects of NLRP3. Here, we examine the scientific evidence supporting a role for NLRP3 and the effects of inhibitors in cardiovascular diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据